Skip to main content
University of Florida (2007, May 26). Stem Cells May Look Malignant, Not Act It. ScienceDaily. Retrieved December 13, 2007, from http://www.sciencedaily.com­ /releases/2007/05/070523134908.htm

This article goes back 6 months but I just noticed it in one of my feeds. It is not clear who the population is exactly but some cancer patients have cancers that also contain normal bone marrow stem cells. They are normal in the sense that they are not malignant but abnormal because they no longer look like bone marrow cells. It was stated that several patients had had bone marrow transplants.

Here is what I think is happening: bone marrow cells escape the bone marrow primarily through the opening that is made in the bone in order to deposit the cells. (it was reported that, prior to receiving the cells, the patients had radiation and/or chemo in order to stop the rejection process. This pretreatment is known to cause cancer in some patients.) However, even with preexisting cancer, the bone marrow cells, dislodged from their normal environment in the bone marrow, will home in on cancer cells that are expressing embryonic CRF's (cell recognition factors) because the bone marrow stem cells have themselves started to express embryonic CRF's. In keeping with the CRF theory, bone marrow stem cells have left their normal environment and begin to find an alternative home by expressing embryonic CRF's that are a good match for the CRF's on the cancer cells.

I don't know if I have mentioned the "homing in" process before but basically it is this: cells sometimes have a need to communicate over long distances as when a group of cells need to establish their own blood supply and "call out" to neighboring blood vessels that they need a blood supply.

Bone marrow stem cells are somewhat unique when it comes to their development. They have an uncanny ability to quickly differentiate into other cells types. It is for this reason that they are not grown in cell culture. Their migration into cancerous tissue may represent an innate ability of the bone marrow stem cells to engage in healing processes.

I'll look out for other studies on this particular stem cell type and its relevance to the CRF theory of cancer.

Comments

Popular posts from this blog

Biological Pathways Symbology

Mutations

This post is based on speculation. It is an attempt at explaining the prevalence of mutations in cancer and their role in perpetuating the cancerous state. The transcriptome of a cell may be classified into two sets: embryonic and adult. There are, of course, conserved elements that form a union of these sets but we are more interested in the embryonic transcriptome exclusive of the union. We now consider the two Nucleotide Excision Repair (NER) mechanisms that have been studied to date: Global Genomic Repair (GGR) and transcription-coupled repair (TCR). Atanassov, et.al. A mutation can take place at or near an adult transcriptome and it is usually repaired by TCR. However, if a mutation takes place at an embryonic transcriptome during the adult stage , TCR can not repair it and, because it is in the adult, GGR may not be able to effect repairs. According to Lans et.al., "Intriguingly, in juvenile and adult animals TCR is the major NER pathway involved in the UV response. Analysi...

What about the unattached cell?

While this procedure is not what I had in mind when I spoke of being able to reprogram the cancer cell, I'm nevertheless glad that reprogramming was found to be possible for the unattached cancer cell. The unattached immune cell is needed everywhere in the body and it would make sense for a cancer derived from an immune cell to differentiate into other immune cells as needed. This is what was found by the Stanford researchers--reprogramming of leukemia cells into normal granulocytes and macrophages via supplied ligands or transcription factors. The initial observation from Stanford came about as a result of a shotgun approach. This approach should also be used for the solid tumor and if their cocktail doesn't do it, I would consider extracting Embryonic Cell Surface molecules from various developmental time points. Finding the right CRF for the differentiation of  solid tumors is right around the corner. My next post will be one showing what the CRF theory helps explain wh...